Anzeige
Mehr »
Login
Montag, 30.12.2024 Börsentäglich über 12.000 News von 681 internationalen Medien
Die Zukunft ist jetzt - KI macht den Unterschied! Smarter. Schneller. Erfolgreicher!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
837 Leser
Artikel bewerten:
(2)

Wellfully and Dolce Cann Global Partner to Disrupt the Medicinal Cannabis Market

Finanznachrichten News

PERTH, Australia, Dec. 22, 2020 /PRNewswire/ -- Boffins have created a revolutionary anti-ageing skin spray - made from super-strength cannabis.

(YEARS) OFF YOUR FACE

Scientists at Australian cannabis company Dolce Cann Global have developed a number of strains which boast a mix of cannabinoids with much stronger anti-inflammatory properties than standard CBD.

Fully integrated wellness company, Wellfully has teamed up with Dolce Cann Global to secure rights to use these strains for products to fight ageing, skin blemishes, acne and arthritis, via its proprietary drug delivery systems.

By merging beauty, science, technology, and proprietary cannabis strains, they aim to create products that use 'ultrasonic diffusion', 'magnetic misting' and other enhanced delivery systems to allow greater absorption and better penetration of the super-strength cannabinoids.

Ultrasonic diffusion allows the skin to absorb droplets which are 50 times smaller than a traditional spray, leaving no undesirable residue on the skin and hair.

The magnetic misting acts on these droplets to further reduce surface tension, and allow for significantly better penetration and absorption.

Scientists are now working on testing using human-derived cell lines to analyse the bio-efficacy on seven key cannabis strains.

The potential for this stronger mix of cannabinoids and their unique activation pathways will be the key to treating anti-inflammatory associated with specific ailments.

The research should go from seed to clinical trials in 12 months, before hitting UK shelves through Wellfully's Reduit brand in 2022.

Wellfully's announcement comes as the cannabis-infused beauty industry continues to grow - and is expected to be worth more than £13 billion per year by 2026.

It is estimated 1.2 billion people in the world suffer from medical conditions for which cannabis has shown to be of therapeutic value.

Paul Peros, CEO of Wellfully, said: "We plan to address the needs of both the health category to treat inflammatory disorders, arthritis, rosacea and muscle recovery damage, as well as beauty for anti-aging, acne, blemishes and beyond."

"The partnership will allow us to deliver potent strains, which research is showing to be much stronger in terms of anti-inflammatory properties than traditional CBD, using our proprietary advanced delivery systems to create new at-home products for the cannabis market.

"With Wellfully's patented technology and go-to-market strategies, resources, brands and network globally, this will open the doors to potential of the highest level when it comes to bringing product delivery and application across sectors using cannabinoid strains that currently do not exist in this manner to consumers. The opportunities are endless and Brits could see the first super-strength cannabis mist via our RÉDUIT beauty brand as early as January 2022."

NOTES TO EDITORS

For interview requests with Paul Peros, CEO of Wellfully Limited, please contact dawn@reduit.com.

Please find all details of the ASX Announcement here

ABOUT WELLFULLY

Wellfully is a fully integrated, science-based wellness company. In addition to its own-brand, RÉDUIT, the Company also offers a portfolio of proprietary technologies and supports partners by providing IP-protected market exclusivity, expertise in magnetic array design, feasibility and efficacy, and claims testing, engineering and production.

Wellfully's established operations via its wholly-owned business units are:

  • The Innovation, R&D unit provides technology to the other business units of the Company, as well as licensing and development services to international partners.
  • The Design & Technology and Supply-chain hub in Dongguan, China has the ability to rapidly develop and industrialize the Company's technologies and innovations in an agile, efficient, secure and cost-effective manner.
  • The Digital Communications and Marketing & Sales units are focused on supporting Wellfully's own consumer brands.
  • BodyGuard is the Company's therapeutic unit and develops advanced "direct to site of injury" patch products for the wellness and pain management sectors. This technology also has applications across supplement, healthcare, and musculoskeletal sectors.

Photo - https://mma.prnewswire.com/media/1390042/Wellfully.jpg
Logo - https://mma.prnewswire.com/media/1390246/Wellfully_Logo.jpg

© 2020 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.